RAPT Therapeutics, Inc. (RAPT) Other Non-Current Assets (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Other Non-Current Assets for 5 consecutive years, with $389000.0 as the latest value for Q3 2024.
- Quarterly Other Non-Current Assets fell 90.75% to $389000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $389000.0 through Sep 2024, down 90.75% year-over-year, with the annual reading at $3.9 million for FY2023, 4.09% down from the prior year.
- Other Non-Current Assets hit $389000.0 in Q3 2024 for RAPT Therapeutics, down from $447000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $4.3 million in Q2 2023 to a low of $389000.0 in Q1 2020.
- Historically, Other Non-Current Assets has averaged $1.9 million across 5 years, with a median of $447000.0 in 2024.
- Biggest five-year swings in Other Non-Current Assets: surged 694.6% in 2022 and later tumbled 90.75% in 2024.
- Year by year, Other Non-Current Assets stood at $389000.0 in 2020, then skyrocketed by 651.16% to $2.9 million in 2021, then skyrocketed by 38.12% to $4.0 million in 2022, then decreased by 4.09% to $3.9 million in 2023, then crashed by 89.95% to $389000.0 in 2024.
- Business Quant data shows Other Non-Current Assets for RAPT at $389000.0 in Q3 2024, $447000.0 in Q2 2024, and $447000.0 in Q1 2024.